These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23225519)

  • 1. End of the line for sirolimus in liver transplant recipients with hepatitis C virus?
    De Simone P; Saliba F; Fischer L
    Liver Transpl; 2013 Feb; 19(2):236-7. PubMed ID: 23225519
    [No Abstract]   [Full Text] [Related]  

  • 2. Sirolimus: more cause for alarm?
    Agarwal PD; Lucey MR
    Liver Transpl; 2012 Sep; 18(9):1003-4. PubMed ID: 22639401
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
    Watt KD; Dierkhising R; Heimbach JK; Charlton MR
    Liver Transpl; 2012 Sep; 18(9):1029-36. PubMed ID: 22641474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of immunosuppression on patient survival after liver transplantation for hepatitis C.
    Mueller AR; Platz K; Willimski C; Berg T; Steinmüller T; Neumann U; Neuhaus R; Hopf U; Radke C; Neuhaus P
    Transplant Proc; 2001; 33(1-2):1347-9. PubMed ID: 11267321
    [No Abstract]   [Full Text] [Related]  

  • 6. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial.
    Asrani SK; Wiesner RH; Trotter JF; Klintmalm G; Katz E; Maller E; Roberts J; Kneteman N; Teperman L; Fung JJ; Millis JM
    Am J Transplant; 2014 Feb; 14(2):356-66. PubMed ID: 24456026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus in liver transplantation.
    Trotter JF
    Transplant Proc; 2003 May; 35(3 Suppl):193S-200S. PubMed ID: 12742496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus and mTOR inhibitors in liver transplantation: the wheel has come full circle.
    Levitsky J; Feng S
    Am J Transplant; 2014 Feb; 14(2):249-50. PubMed ID: 24620373
    [No Abstract]   [Full Text] [Related]  

  • 9. Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation.
    De Ruvo N; Cucchetti A; Lauro A; Masetti M; Cautero N; Di Benedetto F; Dazzi A; Del Gaudio M; Ravaioli M; Di Francesco F; Molteni G; Ramacciato G; Risaliti A; Pinna AD
    Transplantation; 2005 Jul; 80(1):8-12. PubMed ID: 16003226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten years of sirolimus therapy in orthotopic liver transplant recipients.
    Neff GW; Montalbano M; Tzakis AG
    Transplant Proc; 2003 May; 35(3 Suppl):209S-216S. PubMed ID: 12742498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
    Sher LS; Cosenza CA; Petrovic LM; Rojter S; Hoffman A; Lopez RR; Meehan M; Pan SH; Vierling J; Makowka L
    Transplant Proc; 1996 Apr; 28(2):1011-3. PubMed ID: 8623212
    [No Abstract]   [Full Text] [Related]  

  • 12. IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation.
    Langrehr JM; Lohmann R; Guckelberger O; Müller AR; Raakow R; Nüssler NC; Klupp J; Pfitzmann R; Jonas S; Settmacher U; Steinmüller T; Neuhaus P
    Transplant Proc; 2001; 33(1-2):1433-4. PubMed ID: 11267360
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term follow-up in hepatitis C patients with respect to immunosuppression.
    Mueller AR; Platz KP; Berg T; Fukomoto T; Guckelberger O; Neuhaus R; Bechstein WO; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3241-2. PubMed ID: 8962255
    [No Abstract]   [Full Text] [Related]  

  • 14. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P; Samonakis D; Cholongitas E; Patch D; O'Beirne J; Dhillon AP; Rolles K; McCormick A; Hayes P; Burroughs AK
    Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High tacrolimus intra-patient variability is associated with graft rejection, and
    Del Bello A; Congy-Jolivet N; Danjoux M; Muscari F; Lavayssière L; Esposito L; Hebral AL; Bellière J; Kamar N
    World J Gastroenterol; 2018 Apr; 24(16):1795-1802. PubMed ID: 29713132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results.
    Pridöhl O; Heinemann K; Hartwig T; Witzigmann H; Lamesch P; Fangmann J; Berr F; Hauss J; Kohlhaw K
    Transplant Proc; 2001; 33(7-8):3229-31. PubMed ID: 11750384
    [No Abstract]   [Full Text] [Related]  

  • 17. Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506.
    Velio P; Tarantino C; Bertoglio C; Guffanti E; Bardella MT; Biffi R; Andreoni B; Rossi G; Gatti S; Piazzini A; Fassati LR; Galmarini D
    Transplant Proc; 1996 Oct; 28(5):2529-30. PubMed ID: 8907936
    [No Abstract]   [Full Text] [Related]  

  • 18. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Ericzon BG; Bismuth H
    Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract]   [Full Text] [Related]  

  • 19. Sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids: focus on acute rejection, patient and graft survival.
    Yang A; Wang B
    Am J Ther; 2015; 22(2):98-104. PubMed ID: 23921809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
    Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.